• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[利什曼原虫抗原对草原兔尾鼠婴儿利什曼原虫感染的保护作用]

[Protective effects of leishmanial antigens against Leishmania infantum infection in Lagurus lagurus].

作者信息

Chai J, Chang K P, Zuo X, Yan L, Hou Y, Zhang S, Jiang W, Zhang L

机构信息

National Hydatid Disease Centre of China, Institute for Endemic Diseases Control and Research of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 83000.

出版信息

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1999;17(4):237-40.

PMID:12563775
Abstract

AIM

To determine the protective effect of leishmanial surface antigens against experimental visceral leishmaniasis in Lagurus lagurus caused by Leishmania infantum.

METHODS

Recombinant surface protein (rGP63) and lipophosphoglycan (LPG) of Leishmania were used with Corinebacterium parum vaccine as ajuvant to immunize Lagurus lagurus against a challenge with virulent strain of Leishmania infantum. The efficacy of immunoprotection was observed.

RESULTS

When challenged with up to 2 x 10(7) promastigotes, the number of LD on the liver printing sections in the rGP63 + LPG + CP immunised animals was significantly decreased, the parasite reduction rate being 89.79%. LPG + CP gave a parasite reduction rate of 60.6% and rGP63/beta-galactosidase fusion protein + CP showed a parasite reduction rate of 42.45%. Purified rGP63 showed no protection. Immunization with rGP63 + LPG + CP followed by challenge inifection with 1 x 10(6), 5 x 10(6) and 1 x 10(7) promastigotes also showed significantly reduced infection rates.

CONCLUSION

A combination of rGP63 + LPG + CP antigens could provide significant immunoprotection against L. infantum challenge in L. lagurus.

摘要

目的

确定利什曼原虫表面抗原对婴儿利什曼原虫引起的拉古鼠实验性内脏利什曼病的保护作用。

方法

将利什曼原虫的重组表面蛋白(rGP63)和脂磷壁酸(LPG)与短小棒状杆菌疫苗作为佐剂一起用于免疫拉古鼠,使其免受婴儿利什曼原虫强毒株的攻击。观察免疫保护效果。

结果

当用高达2×10⁷前鞭毛体进行攻击时,rGP63 + LPG + CP免疫动物肝脏印片切片上的病变数量显著减少,寄生虫减少率为89.79%。LPG + CP的寄生虫减少率为60.6%,rGP63/β-半乳糖苷酶融合蛋白 + CP的寄生虫减少率为42.45%。纯化的rGP63未显示出保护作用。用rGP63 + LPG + CP免疫后,再用1×10⁶、5×10⁶和1×10⁷前鞭毛体进行攻击感染,也显示感染率显著降低。

结论

rGP63 + LPG + CP抗原组合可为拉古鼠抵御婴儿利什曼原虫攻击提供显著的免疫保护。

相似文献

1
[Protective effects of leishmanial antigens against Leishmania infantum infection in Lagurus lagurus].[利什曼原虫抗原对草原兔尾鼠婴儿利什曼原虫感染的保护作用]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1999;17(4):237-40.
2
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.在法国流行地区使用LiESAp-MDP疫苗对犬内脏利什曼病进行长期保护:双盲随机疗效现场试验。
Vaccine. 2007 May 22;25(21):4223-34. doi: 10.1016/j.vaccine.2007.02.083. Epub 2007 Mar 15.
3
Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.用婴儿利什曼原虫前鞭毛体纯化的排泄分泌抗原来免疫的犬对实验性内脏利什曼病感染的保护作用。
Vaccine. 2005 Apr 22;23(22):2825-40. doi: 10.1016/j.vaccine.2004.11.061.
4
Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.利什曼病的传播阻断疫苗研究:II. 使用硕大利什曼原虫来源的63千道尔顿糖蛋白、脂磷壁酸糖和全寄生虫抗原免疫对BALB/c小鼠硕大利什曼原虫感染进程的影响。
East Afr Med J. 2001 Feb;78(2):90-2.
5
Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi.感染恰加斯利什曼原虫的受试者中T细胞对纯化利什曼原虫抗原反应的特征分析。
Braz J Med Biol Res. 1994 May;27(5):1199-205.
6
Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.用编码KMPII、TRYP、LACK和GP63的质粒DNA进行疫苗接种不能保护犬只免受婴儿利什曼原虫实验性攻击。
Vaccine. 2007 Nov 14;25(46):7962-71. doi: 10.1016/j.vaccine.2007.08.023. Epub 2007 Aug 30.
7
Transmission blocking vaccine studies in leishmaniasis: I. Lipophosphoglycan is a promising transmission blocking vaccine molecule against cutaneous leishmaniasis.利什曼病的传播阻断疫苗研究:I. 脂磷壁酸是一种有前景的针对皮肤利什曼病的传播阻断疫苗分子。
East Afr Med J. 2001 Feb;78(2):84-9. doi: 10.4314/eamj.v78i2.9094.
8
Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.用纯化的婴儿利什曼原虫排泄-分泌抗原免疫的犬淋巴细胞,与利什曼原虫感染的巨噬细胞共同孵育后,会产生γ干扰素,导致一氧化氮介导的无鞭毛体凋亡。
Vet Immunol Immunopathol. 2005 Jul 15;106(3-4):247-57. doi: 10.1016/j.vetimm.2005.03.001.
9
Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis.HSP-70、KMP-11和PFR-2利什曼原虫抗原在犬内脏利什曼病实验模型中的免疫原性。
Vaccine. 2008 Mar 28;26(15):1902-11. doi: 10.1016/j.vaccine.2008.01.042. Epub 2008 Feb 13.
10
Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection.表达LACK蛋白的无抗生素抗性质粒DNA可引发针对婴儿利什曼原虫感染的保护性Th1反应。
Vaccine. 2009 Nov 12;27(48):6695-703. doi: 10.1016/j.vaccine.2009.08.091. Epub 2009 Sep 10.